Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
1,680.00
-65.00 (-3.72%)
Nov 18, 2026, 10:40 AM JST

Nxera Pharma Revenue

Nxera Pharma had revenue of 8.83B JPY in the quarter ending September 30, 2026, with 30.77% growth. This brings the company's total for the last twelve months to 35.51B, up 23.72% year-over-year. In the year 2025, Nxera Pharma had annual revenue of 29.62B with 2.71% growth. That makes Nxera Pharma the 16,750th largest company in the world by revenue and 1,821st in Japan.

Revenue (ttm)
35.51B
Revenue Growth
+23.72%
P/S Ratio
4.49
Revenue / Employee
113.09M
Employees
314
Market Cap
153.54B

Revenue Chart

Revenue by Geography

  • Japan 17.97B 60.7%
  • United States of America 4.89B 16.5%
  • Switzerland 2.17B 7.3%
  • United Kingdom 1.77B 6.0%
  • Bermuda 1.41B 4.7%
  • Germany 1.34B 4.5%
  • Others 74.00M 0.2%
Fiscal year ended Dec 31, 2025 See the full Nxera Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.62B780.00M2.71%
Dec 31, 202428.84B16.07B125.87%
Dec 31, 202312.77B-2.80B-18.00%
Dec 31, 202215.57B-2.14B-12.10%
Dec 31, 202117.71B8.87B100.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GNI Group37.21B
PeptiDream20.48B
3-D Matrix11.92B
RaQualia Pharma3.90B
Heartseed3.03B
Japan Tissue Engineering2.68B
Cuorips72.00M
Healios K.K.47.00M
Revenue Rankings